BostonGene and Exigent Genomic INsight Study
Eligible age
18+ yrs
Accepts
All genders
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Sponsor: BostonGene
You may qualify if…
- ✓ Patients must have a confirmed malignancy of:
- ✓ Locally recurrent, unresectable, or metastatic breast cancer or; Unresectable stage III or metastatic non-small cell lung cancer or; Unresectable or metastatic melanoma or; Locally advanced or metastatic l sarcoma.
- ✓ Life expectancy \> 3 months as per the treating physician
- ✓ Willingness to provide informed consent
- ✓ Living in the United States at time of enrollment
- ✓ Agree to participate in genomic and molecular profiling
You may not qualify if…
- ✕ not meeting the inclusion criteria
Where it's recruiting
Rogers
Stockton
Fort Wayne
Albuquerque
Tulsa
Houston
Puyallup
Source: ClinicalTrials.gov · NCT06272864 · last updated 2025-02-17